levobupivacaine has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Rementería, R; Arcas-Bellas, JJ; Arévalo-Ludeña, J; Martín-Piñeiro, B; Mellado, P; Muñoz-Alameda, LE | 1 |
| Chen, L; Han, C; Hirota, K; Li, T; Ma, D; Masters, J; Wu, L; Zhao, H | 1 |
| D'Hoore, A; Fieuws, S; Penninckx, F; Wolthuis, AM | 1 |
3 other study(ies) available for levobupivacaine and Colonic Neoplasms
| Article | Year |
|---|---|
Anesthetic management of an adult patient with Cor Triatriatum Sinistrum: Utility of transesophageal echocardiography.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Local; Catheters; Colectomy; Colonic Neoplasms; Cor Triatriatum; Echocardiography, Transesophageal; Humans; Levobupivacaine; Male; Monitoring, Intraoperative | 2018 |
Both Bupivacaine and Levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro.
Topics: Anesthetics, Local; Apoptosis; Bupivacaine; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Endoplasmic Reticulum Chaperone BiP; Humans; Levobupivacaine; Melanoma | 2019 |
Outcomes for case-matched single-port colectomy are comparable with conventional laparoscopic colectomy.
Topics: Adenoma; Adult; Aged; Analgesics; Blood Loss, Surgical; Bupivacaine; C-Reactive Protein; Colectomy; Colonic Neoplasms; Crohn Disease; Diverticulitis, Colonic; Female; Humans; Laparoscopy; Length of Stay; Levobupivacaine; Male; Middle Aged; Pain, Postoperative; Statistics, Nonparametric; Sufentanil; Time Factors; Treatment Outcome | 2012 |